LV10959B - Novel 16,17-acetalsubstitute derivatives of pregnane-21-acid, method for their preparation, medicinal preparations of thereof - Google Patents

Novel 16,17-acetalsubstitute derivatives of pregnane-21-acid, method for their preparation, medicinal preparations of thereof Download PDF

Info

Publication number
LV10959B
LV10959B LVP-93-1046A LV931046A LV10959B LV 10959 B LV10959 B LV 10959B LV 931046 A LV931046 A LV 931046A LV 10959 B LV10959 B LV 10959B
Authority
LV
Latvia
Prior art keywords
formula
mji
hjih
compound
compound according
Prior art date
Application number
LVP-93-1046A
Other languages
English (en)
Latvian (lv)
Other versions
LV10959A (lv
Inventor
Paul Hakan Andersson
Per Ture Andersson
Bengt Ingemar Axelsson
Ralph Lennart Brattsand
Bror Arne Thalen
Jan William Trofast
Original Assignee
Draco Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Draco Ab filed Critical Draco Ab
Publication of LV10959A publication Critical patent/LV10959A/xx
Publication of LV10959B publication Critical patent/LV10959B/lv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/0026—Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
LVP-93-1046A 1985-12-19 1993-08-27 Novel 16,17-acetalsubstitute derivatives of pregnane-21-acid, method for their preparation, medicinal preparations of thereof LV10959B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8506015A SE8506015D0 (sv) 1985-12-19 1985-12-19 Novel 16,17-acetalsubstituted pregnane 21-oic acid derivatives

Publications (2)

Publication Number Publication Date
LV10959A LV10959A (lv) 1995-12-20
LV10959B true LV10959B (en) 1996-06-20

Family

ID=20362521

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-1046A LV10959B (en) 1985-12-19 1993-08-27 Novel 16,17-acetalsubstitute derivatives of pregnane-21-acid, method for their preparation, medicinal preparations of thereof

Country Status (31)

Country Link
EP (1) EP0232690B1 (no)
JP (1) JPH0780900B2 (no)
KR (1) KR940004067B1 (no)
CN (1) CN1016508B (no)
AR (1) AR242797A1 (no)
AT (1) ATE57935T1 (no)
AU (1) AU591950B2 (no)
CA (1) CA1318664C (no)
CS (1) CS266597B2 (no)
DD (1) DD256703A5 (no)
DE (1) DE3675378D1 (no)
DK (1) DK168601B1 (no)
ES (1) ES2018656B3 (no)
FI (1) FI84488C (no)
GR (1) GR3001052T3 (no)
HU (1) HU196831B (no)
IE (1) IE59241B1 (no)
IL (1) IL80679A (no)
IS (1) IS1559B (no)
JO (1) JO1499B1 (no)
LT (1) LT3912B (no)
LV (1) LV10959B (no)
MY (1) MY100750A (no)
NO (1) NO164243C (no)
NZ (1) NZ218614A (no)
PH (1) PH23237A (no)
PL (1) PL151627B1 (no)
PT (1) PT83984B (no)
RU (1) RU1839673C (no)
SE (1) SE8506015D0 (no)
ZA (1) ZA868750B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU203769B (en) * 1989-03-09 1991-09-30 Richter Gedeon Vegyeszet Process for producing new steroide derivatives and pharmaceutical compositions containing them
SE8903914D0 (sv) 1989-11-22 1989-11-22 Draco Ab Oral composition for the treatment of inflammatory bowel diseases
US5643602A (en) * 1989-11-22 1997-07-01 Astra Aktiebolag Oral composition for the treatment of inflammatory bowel disease
US6166024A (en) 1995-03-30 2000-12-26 Mayo Foundation For Medical Education And Research Use of topical azathioprine and thioguanine to treat colorectal adenomas
CA2936748C (en) 2014-10-31 2017-08-08 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
US10722473B2 (en) 2018-11-19 2020-07-28 Purdue Pharma L.P. Methods and compositions particularly for treatment of attention deficit disorder

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2204360C2 (de) * 1972-01-27 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE2150268C3 (de) * 1971-10-04 1980-11-06 Schering Ag, 1000 Berlin Und 4619 Bergkamen Pregnansäure-Derivate, Verfahren zu ihrer Herstellung sowie diese enthaltende Arzneimittel
DD95565B1 (de) * 1971-10-04 1986-10-29 Schering Ag Verfahren zur herstellung neuer pregnansaeurederivate
SE378109B (no) * 1972-05-19 1975-08-18 Bofors Ab
DK135380C (da) * 1972-12-22 1977-10-03 Schering Ag Analogifremgangsmade til fremstilling af pregnan-21-syrederivater
DE2264003C2 (de) * 1972-12-22 1982-11-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue Pregnansäure-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
SE8403905D0 (sv) * 1984-07-30 1984-07-30 Draco Ab Liposomes and steroid esters

Also Published As

Publication number Publication date
FI865128A (fi) 1987-06-20
PH23237A (en) 1989-06-06
DK605186D0 (da) 1986-12-16
LT3912B (en) 1996-04-25
JO1499B1 (en) 1988-03-10
ATE57935T1 (de) 1990-11-15
IS3179A7 (is) 1987-06-20
AU6644886A (en) 1987-06-25
AU591950B2 (en) 1989-12-21
NO164243B (no) 1990-06-05
FI84488C (fi) 1991-12-10
ES2018656B3 (es) 1991-05-01
IE59241B1 (en) 1994-01-26
LV10959A (lv) 1995-12-20
HU196831B (en) 1989-01-30
NZ218614A (en) 1989-02-24
KR870006081A (ko) 1987-07-09
NO865004L (no) 1987-06-22
HUT44273A (en) 1988-02-29
ZA868750B (en) 1987-08-26
NO164243C (no) 1990-09-19
FI865128A0 (fi) 1986-12-16
KR940004067B1 (ko) 1994-05-11
CN86108634A (zh) 1987-07-22
IL80679A (en) 1992-03-29
RU1839673C (ru) 1993-12-30
DE3675378D1 (de) 1990-12-06
AR242797A1 (es) 1993-05-31
DK605186A (da) 1987-06-20
CN1016508B (zh) 1992-05-06
CS266597B2 (en) 1990-01-12
PT83984A (en) 1987-01-01
PL263041A1 (en) 1988-07-21
CS960486A2 (en) 1989-04-14
DK168601B1 (da) 1994-05-02
FI84488B (fi) 1991-08-30
SE8506015D0 (sv) 1985-12-19
IS1559B (is) 1994-10-05
JPS62155296A (ja) 1987-07-10
LTIP1682A (en) 1995-07-25
JPH0780900B2 (ja) 1995-08-30
GR3001052T3 (en) 1992-03-20
EP0232690B1 (en) 1990-10-31
CA1318664C (en) 1993-06-01
PT83984B (pt) 1989-07-31
EP0232690A1 (en) 1987-08-19
MY100750A (en) 1991-02-14
DD256703A5 (de) 1988-05-18
IL80679A0 (en) 1987-02-27
IE863245L (en) 1987-06-19
NO865004D0 (no) 1986-12-11
PL151627B1 (en) 1990-09-28

Similar Documents

Publication Publication Date Title
KR100257692B1 (ko) 아가트로반의 농축수용액
DE2661011C2 (de) 17ß-Ester von Östradiol
LV10959B (en) Novel 16,17-acetalsubstitute derivatives of pregnane-21-acid, method for their preparation, medicinal preparations of thereof
WO2010120232A1 (en) A prodrug comprising beta-keto carboxylic acid, beta-keto carboxylic acid salt or beta-keto carboxylic acid ester for drug delivery
JP2015512937A5 (no)
CA2325542A1 (en) Acid labile prodrugs
WO2004080383B1 (en) Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
CA2842177A1 (en) Formulations of deoxycholic acid and salts thereof
US4780455A (en) Lipophilic complexes of pharmacologically active organic compounds
GB2053924A (en) Immunosuppressive 3-hemiesters of7-oxygenated cholesterol
CZ20013497A3 (cs) Erythromycinové deriváty
IE43859B1 (en) 5 -estrane compounds and pharmaceutical compositions containing same
EP3305298B1 (en) Formulations of deoxycholic acid and salts thereof
Kumpulainen et al. Synthesis, in vitro and in vivo characterization of novel ethyl dioxy phosphate prodrug of propofol
Samsioe Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel+ 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel+ 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers
KR950006218B1 (ko) 페닐퀴놀린 카복실산의 동결건조 약제 조성물
US3365475A (en) Process for the preparation of 17alpha-(3'-hydroxy-propyl)-4-androstene-3beta, 17beta-diol
Forbes et al. Effect of lntraperitoneal Administration of Alcohol on the Adrenal Levels of Cholesterol and Ascorbic Acid in Rats and Guinea Pigs
Kuroki et al. Comparative effects of deoxycholate and 7‐methyl‐deoxycholate in the hamster
EP0092073B1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
KR890002128A (ko) 실비빈의 가용성 유도체, 그것의 제조방법 및 그것을 함유하는 제약학적 조성물
RU2678313C1 (ru) Способ снижения токсического повреждения печени крыс четыреххлористым углеродом
Nakagaki et al. Effect of female sex hormones on lithogenicity of bile
Kreis et al. Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors
EP0035770A2 (en) An orally administered drug form comprising a glycosidic antibiotic and an adjuvant